Insider Trading History of Gottesdiener Keith Michael


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gottesdiener Keith Michael since year 2005. The trader's CIK number is 1615856. At the time of the last reporting, Gottesdiener Keith Michael was the CEO and President of Rhythm Pharmaceuticals, Inc. . (stock ticker symbol RYTM). See this page for all insider trading activities at Rhythm Pharmaceuticals, Inc. .

Note that in the past Gottesdiener Keith Michael also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Gottesdiener Keith Michael since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-07-16 RYTM Rhythm Pharmaceuticals, Inc. Option Ex 7,500 4.59 34,425
2019-03-15 RYTM Rhythm Pharmaceuticals, Inc. Sale 7,961 30.04 239,148
2019-03-18 RYTM Rhythm Pharmaceuticals, Inc. Sale 2,329 30.27 70,498
2019-03-13 RYTM Rhythm Pharmaceuticals, Inc. Sale 7,782 30.06 233,926
2019-03-14 RYTM Rhythm Pharmaceuticals, Inc. Sale 1,506 30.05 45,255
2019-02-27 RYTM Rhythm Pharmaceuticals, Inc. Sale 1,814 30.01 54,438
2019-02-26 RYTM Rhythm Pharmaceuticals, Inc. Sale 635 30.13 19,132
2019-02-15 RYTM Rhythm Pharmaceuticals, Inc. Sale 12,002 30.02 360,300
2019-02-19 RYTM Rhythm Pharmaceuticals, Inc. Sale 918 30.05 27,585
2019-02-13 RYTM Rhythm Pharmaceuticals, Inc. Sale 3,934 30.00 118,020
2019-01-22 RYTM Rhythm Pharmaceuticals, Inc. Sale 15,674 30.05 471,003
2019-01-23 RYTM Rhythm Pharmaceuticals, Inc. Sale 105 30.21 3,172
2019-01-18 RYTM Rhythm Pharmaceuticals, Inc. Sale 10,115 30.01 303,551
2019-01-16 RYTM Rhythm Pharmaceuticals, Inc. Sale 662 30.00 19,860
2018-12-03 RYTM Rhythm Pharmaceuticals, Inc. Sale 563 30.00 16,890
2018-11-02 RYTM Rhythm Pharmaceuticals, Inc. Sale 16,500 30.08 496,320
2018-05-09 RYTM Rhythm Pharmaceuticals, Inc. Option Ex 3,000 4.59 13,770
2018-04-09 ICPT Intercept Pharmaceuticals, Inc. Buy 1,171 64.00 74,944

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gottesdiener Keith Michael (CEO and President of Rhythm Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month